TABLE 2.
Potential Causes and Pathogenic Mechanisms underlying CAE.
| Cause | Pathogenic mechanism of coronary ectasia |
|---|---|
| Atherosclerosis | Local mechanical stress from stenosis, enhanced inflammatory response-induced proteolysis of extracellular matrix proteins |
| Kawasaki disease | Autoimmunity, vasculitis |
| Genetic susceptibility | Specific HLA class II genotypes such as HLA-DR B1*13 are more detectable |
| Inflammatory disorders (vasculitis)/connective tissue disorders | Increased plasma levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin; imbalances in protein levels of matrix metalloproteinase and its tissue inhibitor |
| Coronary Fistula | Compensatory dilatation secondary to a high-flow state |
| Coronary anomalies | Compensatory dilatation secondary to (e.g., ALCAPA) myocardial ischemia |
| Infection | Direct pathogen invasion of arterial wall, immune complex deposition |
| Trauma/iatrogenic | Mechanical and shear wall stress, and non-healing dissections |
| Drug-related | Vasoconstriction/endothelial damage |
HLA, human leukocyte antigen; ALCAPA, anomalous origin of the left coronary artery from the pulmonary artery.